| Rezolute, Inc. |
38.52 |
| Soleno Therapeutics, Inc. |
25.93 |
| New Frontier Health Corporation |
10.85 |
| Terns Pharmaceuticals, Inc. |
10.3 |
| Unicycive Therapeutics, Inc. |
9.98 |
| Gracell Biotechnologies Inc. |
9.87 |
| Instil Bio, Inc. |
9.6 |
| IO Biotech, Inc. |
9.37 |
| Bolt Biotherapeutics, Inc. |
9.24 |
| Genetron Holdings Limited |
8.56 |
| ALX Oncology Holdings Inc. |
8.41 |
| Verona Pharma plc |
8.2 |
| Compass Therapeutics, Inc. |
6.82 |
| Astria Therapeutics, Inc. |
5.6 |
| Tarsus Pharmaceuticals, Inc. |
5.21 |
| Sera Prognostics, Inc. |
5.09 |
| Aligos Therapeutics, Inc. |
4.69 |
| Harmony Biosciences Holdings, Inc. |
4.59 |
| Geron Corporation |
4.41 |
| VectivBio Holding AG |
3.72 |
| Kadmon Holdings, Inc. |
3.36 |
| Olema Pharmaceuticals, Inc. |
3.35 |
| enGene Holdings Inc. |
2.93 |
| COMPASS Pathways plc |
2.6 |
| Tourmaline Bio, Inc. |
2.31 |
| Amyris, Inc. |
2.1 |
| Aadi Bioscience, Inc. |
2.08 |
| Silence Therapeutics plc |
1.7 |
| DBV Technologies S.A. |
1.4 |
| Homology Medicines, Inc. |
0.64 |
| Delcath Systems, Inc. |
0 |
